RXQ Compounding Recalls Fentanyl and Bupivacaine Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Fentanyl and Bupivacaine syringes nationwide due to a lack of assurance of sterility.
- Product
- FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89
- Category
- Drug
- Distribution
- Distributed nationwide